The study revealed that those patients with Barth syndrome, who underwent application of recombinant G‐CSF to treat their severe neutropenia scored higher in all domains of the Sniffin' Sticks smell test than a group of patients with Barth syndrome who have not received any G‐CSF. The gene discussed is CSF3; the disease is Decreased total neutrophil count.